1. Programmed cell death 5 suppresses AKT-mediated cytoprotection of endothelium
   Seung-Hyun Lee et al, 2018, Proceedings of the National Academy of Sciences CrossRef
2. RhPDCD5 combined with dexamethasone increases antitumor activity in multiple myeloma partially via inhibiting the Wnt signalling pathway
   Qian Cheng et al, 2018, Clinical and Experimental Pharmacology and Physiology CrossRef
3. PDCD5 regulates cell proliferation, cell cycle progression and apoptosi
   Penghui Li et al, 2017, Oncology Letters CrossRef
4. From driver genes to gene families: A computational analysis of oncogenic mutations and ubiquitination anomalies in hepatocellular carcinoma
   Meng Wang et al, 2024, Computational Biology and Chemistry CrossRef
5. The Molecular Evolution and Functional Divergence of Lamprey Programmed Cell Death Genes
   Xin Guan et al, 2019, Frontiers in Immunology CrossRef
6. Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma
   Shunichi Tsuge et al, 2019, Gastrointestinal Tumors CrossRef
7. The roles of serum PDCD5 in circulating CD133 positive cells of the patients with gastric cancer
   Dan Wang et al, 2016, Tumor Biology CrossRef
8. Roles of programmed cell death protein 5 in inflammation and cancer (Review)
   Wei Wang et al, 2016, International Journal of Oncology CrossRef
9. Lithium effects on vesicular trafficking in hepatocellular carcinoma cells
   Iuliia Taskaeva et al, 2019, Ultrastructural Pathology CrossRef